| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 47.40M | 91.89M | 84.37M | 88.19M | 143.87M |
| Gross Profit | 4.26M | 6.49M | 21.22M | 38.49M | 65.27M |
| EBITDA | -29.35M | -28.31M | -36.05M | -30.94M | -35.40M |
| Net Income | -35.56M | -35.85M | -49.32M | -43.21M | -44.35M |
Balance Sheet | |||||
| Total Assets | 146.75M | 137.47M | 165.74M | 193.80M | 190.72M |
| Cash, Cash Equivalents and Short-Term Investments | 27.09M | 2.30M | 33.95M | 11.36M | 32.35M |
| Total Debt | 46.22M | 60.74M | 71.40M | 79.92M | 32.92M |
| Total Liabilities | 87.06M | 95.08M | 107.53M | 113.90M | 66.58M |
| Stockholders Equity | 58.83M | 42.06M | 58.21M | 80.36M | 124.27M |
Cash Flow | |||||
| Free Cash Flow | -12.47M | -35.37M | 13.80M | -76.70M | -13.24M |
| Operating Cash Flow | -12.47M | -35.21M | 14.42M | -75.93M | -11.02M |
| Investing Cash Flow | 0.00 | -101.00K | -2.00K | 15.03M | 6.67M |
| Financing Cash Flow | 36.67M | 3.63M | 8.13M | 39.30M | -10.74M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | HK$701.42B | 11.05 | 19.76% | 5.00% | 9.21% | 4.23% | |
71 Outperform | HK$451.19M | ― | 6.20% | 12.90% | 0.71% | 2.66% | |
68 Neutral | HK$213.24B | 9.19 | 15.65% | 5.20% | 2.10% | -0.45% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | HK$488.10M | 5.16 | 4.84% | 7.24% | -6.53% | -49.31% | |
48 Neutral | HK$5.34B | -35.42 | -4.81% | ― | 4.06% | -469.59% | |
45 Neutral | HK$176.77M | -3.28 | -48.35% | ― | -48.40% | 59.08% |